CollPlant Biotechnologies Ltd. announced that it has entered into a definitive agreement for the issuance and sale of 1,600,000 ordinary shares at $1.25 per share in a registered direct offering. In a concurrent private placement, the company will issue unregistered series A and series B warrants, each to purchase up to 1,600,000 ordinary shares at an exercise price of $1.25 per share. The series A warrants will be exercisable immediately and expire five years after the effective date of a registration statement for the underlying shares, while the series B warrants will be exercisable immediately and expire eighteen months after the effective date of a registration statement. The ordinary shares underlying the warrants have not been registered under the Securities Act and may only be offered or sold in the United States pursuant to an effective registration statement or an applicable exemption.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Collplant Biotechnologies Ltd. published the original content used to generate this news brief on February 05, 2026, and is solely responsible for the information contained therein.